TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 122 filers reported holding TG THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $24,000 | -52.0% | 4,300 | -65.9% | 0.01% | -62.5% |
| Q4 2018 | $50,000 | -60.0% | 12,600 | +32.6% | 0.02% | -42.9% |
| Q2 2018 | $125,000 | -7.4% | 9,500 | -1.0% | 0.03% | -15.2% |
| Q1 2018 | $135,000 | +419.2% | 9,600 | +200.0% | 0.03% | +450.0% |
| Q4 2017 | $26,000 | +225.0% | 3,200 | +300.0% | 0.01% | +500.0% |
| Q2 2017 | $8,000 | – | 800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,880,323 | $38,633,000 | 2.30% |
| Eversept Partners, LP | 773,501 | $4,343,208 | 1.35% |
| Opaleye Management Inc. | 612,500 | $3,439,000 | 1.24% |
| BRIDGER MANAGEMENT, LLC | 2,334,196 | $13,107,000 | 1.08% |
| Sofinnova Investments, Inc. | 1,733,628 | $9,734,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 354,719 | $1,992,000 | 0.34% |
| 683 Capital Management, LLC | 400,000 | $2,246,000 | 0.25% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 649,460 | $3,646,000 | 0.23% |
| Artal Group S.A. | 900,000 | $5,054,000 | 0.20% |
| Frontier Wealth Management LLC | 226,750 | $1,273,000 | 0.19% |